Rare Cancers in Europe: Challenges and Solutions

TITLE	SESSION	AUTHOR
Recommendations from workshop addressing “Organisational Challenges”	ADDRESSING GAPS IN RARE TUMOUR TREATMENTS IN EUROPE: EXPLORING SOLUTIONS	Jean-Yves Blay
Rare tumours and the patient perspective	EUROPEAN VISION & EU ACTION: PANEL DISCUSSIONS	Sandy Craine
The industry perspective	EUROPEAN VISION & EU ACTION: PANEL DISCUSSIONS	Guido Guidi
The role of the Organisation of European Cancer Institutes (OECI)	EUROPEAN VISION & EU ACTION: PANEL DISCUSSIONS	Marco Pierotti
Welcome remarks and introduction by José Baselga, President of ESMO	OPENING SESSION	José Baselga
A parliamentary perspective	PARALLEL BREAKOUT SESSIONS INCLUDING WORKING LUNCH	Jolan ta Dickute
Challenges and barriers: An overview	PARALLEL BREAKOUT SESSIONS INCLUDING WORKING LUNCH	Yann Le Cam
Current guidelines on efficacy assessment in the EU	PARALLEL BREAKOUT SESSIONS INCLUDING WORKING LUNCH	Iordanis Gravanis
The orphan drugs approval process	PARALLEL BREAKOUT SESSIONS INCLUDING WORKING LUNCH	Filippo De Braud
The role of patient advocacy groups	PARALLEL BREAKOUT SESSIONS INCLUDING WORKING LUNCH	Jan Geissler